Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Expert Opinion on Investigational Drugs|January 5, 2002
Concepts in the use of TRAIL/Apo2L: an emerging biotherapy for myeloma and other neoplasiasN Mitsiades, C S Mitsiades, V Poulaki, et al.
Thyroid : Official Journal of the American Thyroid Association|August 25, 2000
Fas ligand expression in thyroid follicular cells from patients with thionamide-treated Graves' diseaseN Mitsiades, V Poulaki, S Tseleni-Balafouta, et al.
Trends in Endocrinology and Metabolism: TEM|October 12, 2001
Apoptosis induced by FasL and TRAIL/Apo2L in the pathogenesis of thyroid diseasesN Mitsiades, V Poulaki, C S Mitsiades, et al.
Oncogene|June 26, 2001
The Gem GTP-binding protein promotes morphological differentiation in neuroblastomaA Leone, N Mitsiades, Y Ward, et al.
Investigative Ophthalmology & Visual Science|October 3, 2001
Inhibition of inflammatory corneal angiogenesis by TNP-470A M Joussen, W D Beecken, Y Moromizato, et al.
The Journal of Clinical Endocrinology and Metabolism|June 17, 1998
Fas/Fas ligand up-regulation and Bcl-2 down-regulation may be significant in the pathogenesis of Hashimoto's thyroiditisN Mitsiades, V Poulaki, V Kotoula, et al.
Investigative Ophthalmology & Visual Science|November 1, 2001
In vivo retinal gene expression in early diabetesA M Joussen, S Huang, V Poulaki, et al.
Pageof 3